At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 164 enrolled
Drug / intervention
Placebo vaginal ring +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Open Label, Randomized, Two-period Crossover Study on the Insertion of MK-8342A (NuvaRing®) Placebo With and Without the Use of NuvaRing Applicator in Healthy Female Subjects
In Brief
A Phase 3 clinical trial evaluating Placebo vaginal ring and Single-use, non-sterile applicator for Contraception: Optional Applicator for Insertion of Vaginal Ring. Completed, enrolled 164 participants.
Detailed Summary
The purpose of the study is to assess the performance and safe use of the vaginal ring applicator as an optional aid for insertion of a placebo vaginal ring into the vagina in healthy women
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 2014
Enrollment StartDec 2014
Primary CompletionApr 2015
TodayJul 2026
First PostedOct 27, 2014
Enrollment StartDec 11, 2014
Primary CompletionApr 10, 2015
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 11.7 years ago
Interventions
Placebo vaginal ringdrug
Drug-free placebo vaginal ring
Single-use, non-sterile applicatordevice
Single-use, non-sterile, plastic applicator for insertion of vaginal ring.